Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Select Medical HoldingsFRA:S24 77 EV-to-EBITDA is 10.52 as of Aug. 24, 2026, which is 24% above its 10-year median of 8.50. GuruFocus rates FRA:S24 with a GF Score™ of 77/100 and a GF Value™ of €15.10. The stock has 7 warning signs investors should review. Among 516 Healthcare Providers & Services companies, Select Medical Holdings ranks better than 52.13% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Select Medical Holdings's enterprise value is €4,694 Mil.
Select Medical Holdings's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was €446 Mil. Therefore, Select Medical Holdings's EV-to-EBITDA for today is 10.52.
The historical rank and industry rank for Select Medical Holdings's EV-to-EBITDA or its related term are showing as below:
FRA:S24'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 5.72 Med: 8.5 Max: 21.89
Current: 10.33
During the past 13 years, the highest EV-to-EBITDA of Select Medical Holdings was 21.89. The lowest was 5.72. And the median was 8.50.
FRA:S24's EV-to-EBITDA is ranked better than 52.13% of 516
companies
in the Healthcare Providers & Services industry
Industry Median: 10.705
vs FRA:S24: 10.33
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Select Medical Holdings (FRA:S24) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Select Medical Holdings's PE Ratio (TTM) for today is calculated as:
Select Medical Holdings's share price for today is €14.40.
Select Medical Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.913.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Select Medical Holdings's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Select Medical Holdings EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Select Medical Holdings's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Select Medical Holdings's EV-to-EBITDA falls into.
Select Medical Holdings's current Enterprise Value is €4,694 Mil.
Select Medical Holdings's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €446 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Select Medical Holdings (FRA:S24) has a EV-to-EBITDA of 10.52 as of Aug. 24, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Select Medical Holdings. This is 24% above median its historical median of 8.50. Over the past decade, Select Medical Holdings' EV-to-EBITDA has ranged from 5.72 to 21.89. According to the industry distribution chart, Select Medical Holdings ranks #247 out of 516 companies in the Healthcare Providers & Services industry, placing it in the top 47.9%.
Is Select Medical Holdings' EV-to-EBITDA too high?
Select Medical Holdings' current EV-to-EBITDA of 10.52 is 24% above median its 10-year median of 8.50. Over the past 10 years, this metric has ranged from a low of 5.72 to a high of 21.89. The Healthcare Providers & Services industry median EV-to-EBITDA is 10.71. Select Medical Holdings' value of 10.52 is 1.7% below this industry median. Based on the distribution chart, Select Medical Holdings ranks #247 out of 516 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Select Medical Holdings has a GF Score™ of 77/100, reflecting its overall financial health beyond just this single metric.
How does Select Medical Holdings' EV-to-EBITDA compare to SGRY and MD?
According to the Healthcare Providers & Services industry distribution chart, Select Medical Holdings ranks #247 out of 516 companies for EV-to-EBITDA. This puts Select Medical Holdings in the upper half of its industry. The industry median EV-to-EBITDA is 10.71. Select Medical Holdings' value of 10.52 is 1.7% below this benchmark. Historically, Select Medical Holdings' own EV-to-EBITDA has ranged from 5.72 to 21.89 over the past decade. While the company's 10-year median is 8.50 vs. the industry median of 10.71, Select Medical Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 10.71, based on 516 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Select Medical Holdings's current EV-to-EBITDA of 10.52 is 1.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Select Medical Holdings. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 10.71 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Select Medical Holdings's current EV-to-EBITDA is 10.52, which is 24% above median its own 10-year median of 8.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Select Medical Holdings stock overvalued right now?
Select Medical Holdings (FRA:S24) has a current EV-to-EBITDA of 10.52. The stock's GF Value™ is €15.10, compared to a current price of €14.40 — trading 4.6% below its estimated fair value. The current EV-to-EBITDA is 10.52, which is 24% above median its 10-year median of 8.50 and 1.7% below the Healthcare Providers & Services industry median of 10.71. Select Medical Holdings' overall GF Score™ is 77/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Select Medical Holdings (FRA:S24), the current EV-to-EBITDA is 10.52 as of Aug. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Select Medical Holdings (FRA:S24) Overvalued in 2026?
Based on GuruFocus' analysis, Select Medical Holdings stock appears to be undervalued.
The current stock price of €14.40 is trading 4.6% below its estimated GF Value™ of €15.10.
Key valuation signals for FRA:S24:
EV-to-EBITDA: 10.52 (24% above median its 10-year median of 8.50)
GF Value™: €15.10 vs. price of €14.40 (4.6% below fair value)
Industry Position: 1.7% below the Healthcare Providers & Services median (#247 of 516)
No single metric tells the full story. See the FRA:S24 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Select Medical Holdings Corp is a healthcare company that operates through three segments: critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics. Critical illness recovery hospitals which derives maximum revenue consists of hospitals designed to serve the needs of patients recovering from critical illnesses, often with complex medical needs. The rehabilitation hospital segment consists of hospitals designed to serve patients that require intensive physical rehabilitation care. Patients are typically admitted to critical illness recovery hospitals and rehabilitation hospitals from general acute care hospitals. The outpatient rehabilitation segment consists of clinics that provide physical, occupational, and speech rehabilitation services.
77GF Score
Get the complete analysis for FRA:S24
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:S24 has been successfully added to your 
